RT @FrontCellInfect: Lipopolysaccharide Preparation Derived From Porphyromonas gingivalis Induces a Weaker Immuno-Inflammatory Response in…
Lipopolysaccharide Preparation Derived From <em>Porphyromonas gingivalis</em> Induces a Weaker Immuno-Inflammatory Response in BV-2 Microglial Cells Than <em>Escherichia coli</em> by Differentially Activating TLR2/4-Mediated NF-κB/S
New article: Lipopolysaccharide Preparation Derived From Porphyromonas gingivalis Induces a Weaker Immuno-Inflammatory Response in BV-2 Microglial Cells Than Escherichia coli by Differentially Activating TLR2/4-Mediated NF-κB/STAT3… https://t.co/OKuxOd7Bj8
Lipopolysaccharide Preparation Derived From Porphyromonas gingivalis Induces a Weaker Immuno-Inflammatory Response in BV-2 Microglial Cells Than Escherichia coli by Differentially Activating TLR2/4-Mediated NF-κB/STAT3 Signaling Pathways https://t.co/PeO8